EMAIL THIS PAGE TO A FRIEND

Cancer research

Accelerated tumor progression in mice lacking the ATP receptor P2X7.


PMID 25542861

Abstract

The ATP receptor P2X7 (P2X7R or P2RX7) has a key role in inflammation and immunity, but its possible roles in cancer are not firmly established. In the present study, we investigated the effect of host genetic deletion of P2X7R in the mouse on the growth of B16 melanoma or CT26 colon carcinoma cells. Tumor size and metastatic dissemination were assessed by in vivo calliper and luciferase luminescence emission measurements along with postmortem examination. In P2X7R-deficient mice, tumor growth and metastatic spreading were accelerated strongly, compared with wild-type (wt) mice. Intratumoral IL-1β and VEGF release were drastically reduced, and inflammatory cell infiltration was abrogated nearly completely. Similarly, tumor growth was also greatly accelerated in wt chimeric mice implanted with P2X7R-deficient bone marrow cells, defining hematopoietic cells as a sufficient site of P2X7R action. Finally, dendritic cells from P2X7R-deficient mice were unresponsive to stimulation with tumor cells, and chemotaxis of P2X7R-less cells was impaired. Overall, our results showed that host P2X7R expression was critical to support an antitumor immune response, and to restrict tumor growth and metastatic diffusion.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

P8232
Anti-P2X7 Purinergic Receptor antibody produced in rabbit, affinity isolated antibody, lyophilized powder
L9504
D-Luciferin, synthetic
C11H8N2O3S2
L6152
D-Luciferin, synthetic, BioXtra, ≥99% (HPLC)
C11H8N2O3S2
95321
Hydrogen peroxide solution, ≥30%, for trace analysis
H2O2
16911
Hydrogen peroxide solution, for ultratrace analysis
H2O2
88597
Hydrogen peroxide solution, 3%, for microbiology
H2O2
95294
Hydrogen peroxide solution, tested according to Ph Eur
H2O2
95660
o-Xylene, analytical standard
C8H10
295884
o-Xylene, for HPLC, 98%
C8H10
PHR1312
o-Xylene, Pharmaceutical Secondary Standard; Certified Reference Material
C8H10
T1378
Sigma 7-9®, ≥99% (titration), crystalline
C4H11NO3
252859
Tris(hydroxymethyl)aminomethane, ACS reagent, ≥99.8%
C4H11NO3
T6066
Trizma® base, BioPerformance Certified, meets EP, USP testing specifications, suitable for cell culture, ≥99.9% (titration)
C4H11NO3
93362
Trizma® base, BioUltra, for molecular biology, ≥99.8% (T)
C4H11NO3
T6791
Trizma® base, BioXtra, pH 10.5-12.0 (1 M in H2O), ≥99.9% (titration)
C4H11NO3
T4661
Trizma® base, ≥99.9% (titration), crystalline
C4H11NO3
93352
Trizma® base, ≥99.0% (T)
C4H11NO3
RDD008
Trizma® base, anhydrous, free-flowing, Redi-Dri, ≥99.9%
C4H11NO3
93440
Trizma® base, certified reference material for titrimetry, certified by BAM, ≥99.5%
C4H11NO3
93350
Trizma® base, puriss. p.a., ≥99.7% (T)
C4H11NO3
T2550000
Trometamol, European Pharmacopoeia (EP) Reference Standard
C4H11NO3
T6687
Tromethamine, meets USP testing specifications
C4H11NO3
RES3193T-A7
Tromethamine, PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production, suitable for cell culture, Meets USP, EP, JPC, BP testing specifications.
C4H11NO3
1698002
Tromethamine, United States Pharmacopeia (USP) Reference Standard
C4H11NO3
PHR1347
Tromethamine, Pharmaceutical Secondary Standard; Certified Reference Material
C4H11NO3